1 active not recruiting, 1 completed, 1 recruiting. 2 Phase 2, 1 Not applicable, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Active not recruiting 1, Completed 1 |
| Not applicable | 1 | Recruiting 1 |
| Phase 3 | 1 | Completed 1 |
Follow Endometrial Neoplasm Malignant Stage I: new trials by email Literature Review of Endometrial Neoplasm Malignant Stage I trials Research Report on Endometrial Neoplasm Malignant Stage I
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Gonadotropin-releasing Hormone Agonist (GnRHa) Plus Letrozole In Young Women With Early Endometrial Cancer Megestrol Acetate 160 MG Oral Tablet, Medroxyprogesterone Acetate 500 MG, Triprorelin Acetate - Endometrial Neoplasm Malignant Stage I | Phase 2 | Active not recruiting | Fudan University | 104 | 2022-03-11 | 2026-10-23 |
| Megestrol Acetate Plus LNG-IUS in Young Women With Early Endometrial Cancer Megestrol Acetate, Levonorgestrel-releasing Intrauterine System(LNG-IUS) - Endometrial Neoplasm Malignant Stage I | Phase 2 / Phase 3 | Completed | Fudan University | 64 | 2017-07-04 | 2020-11-20 |
| Fertility-sparing Therapy for Patients With Stage IA Endometrial Cancer Indication-extended Fertility-sparing Therapy - Endometrial Neoplasms, Endometrial Neoplasm Malignant | Not applicable | Recruiting | Peking University People's Hospital | 57 | 2016-08-01 | 2023-07-14 |
Endometrial Neoplasms (3) · Carcinoma, Endometrioid (1)
Female Urogenital Diseases (3) · Female Urogenital Diseases and Pregnancy Complications (3) · Genital Diseases (3) · Genital Diseases, Female (3) · Genital Neoplasms, Female (3) · Neoplasms (3) · Neoplasms by Site (3) · Urogenital Diseases (3) · Urogenital Neoplasms (3) · Uterine Diseases (3) · Uterine Neoplasms (3) · Adenocarcinoma (1) · Adnexal Diseases (1) · Carcinoma (1) · Endocrine System Diseases (1)
Megestrol Acetate (2) · Letrozole (1) · Medroxyprogesterone Acetate (1) · Tablets (1)
Fudan University (2) · Peking University People's Hospital (1)
China (3)